Robert N. Fried

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Los Angeles, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jeong James Lee, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert N. Fried

Form 4 holding Chief Executive Officer, Director

Niagen Bioscience, Inc.

Security class
Common Stock
Shares / value
250,000
Estimated value
$1,102,500
Report date
24 Apr 2026
Price
$4.41
Ownership
By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020
Form 4 holding Chief Executive Officer, Director

Niagen Bioscience, Inc.

Security class
Common Stock
Shares / value
250,000
Estimated value
$1,102,500
Report date
24 Apr 2026
Price
$4.41
Ownership
By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020
Form 4 holding Chief Executive Officer, Director

Niagen Bioscience, Inc.

Security class
Common Stock
Shares / value
95,001
Estimated value
$418,954
Report date
24 Apr 2026
Price
$4.41
Ownership
By Fried-Travis Revocable Trust U/A Dated 06/02/1999
Form 4 holding Chief Executive Officer, Director

ChromaDex Corp.

Security class
Performance Stock Unit
Shares / value
1,518,600
Estimated value
Report date
25 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Niagen Bioscience, Inc.

Security class
Employee Stock Options (right to buy)
Shares / value
503,937
Estimated value
Report date
19 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Niagen Bioscience, Inc.

Security class
Stock Options (right to buy)
Shares / value
0
Estimated value
Report date
24 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert N. Fried

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .